Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Icecure Medical Ltd (NASDAQ: ICCM) closed at $1.14 down -3.39% from its previous closing price of $1.18. In other words, the price has decreased by -$3.39 from its previous closing price. On the day, 0.52 million shares were traded. ICCM stock price reached its highest trading level at $1.215 during the session, while it also had its lowest trading level at $1.11.
Ratios:
For a deeper understanding of Icecure Medical Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.67. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICCM now has a Market Capitalization of 66751444 and an Enterprise Value of 52262924. For the stock, the TTM Price-to-Sale (P/S) ratio is 17.57 while its Price-to-Book (P/B) ratio in mrq is 6.21. Its current Enterprise Value per Revenue stands at 14.237 whereas that against EBITDA is -3.667.
Stock Price History:
Over the past 52 weeks, ICCM has reached a high of $1.66, while it has fallen to a 52-week low of $0.48. The 50-Day Moving Average of the stock is -13.49%, while the 200-Day Moving Average is calculated to be 27.77%.
Shares Statistics:
For the past three months, ICCM has traded an average of 370.86K shares per day and 419490 over the past ten days. A total of 54.78M shares are outstanding, with a floating share count of 29.11M. Insiders hold about 48.54% of the company’s shares, while institutions hold 0.27% stake in the company. Shares short for ICCM as of 1741910400 were 285526 with a Short Ratio of 0.77, compared to 1739491200 on 773284. Therefore, it implies a Short% of Shares Outstanding of 285526 and a Short% of Float of 0.9599999499999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 1.0 analysts are dedicated to thoroughly evaluating and rating the performance of Icecure Medical Ltd (ICCM) in the stock market.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.26 and -$0.29 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.25, with 2.0 analysts recommending between -$0.21 and -$0.28.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $1.07M this quarter.It ranges from a high estimate of $1.2M to a low estimate of $935k. As of the current estimate, Icecure Medical Ltd’s year-ago sales were $1.25MFor the next quarter, 2 analysts are estimating revenue of $952.5k. There is a high estimate of $1M for the next quarter, whereas the lowest estimate is $905k.
A total of 3 analysts have provided revenue estimates for ICCM’s current fiscal year. The highest revenue estimate was $3.62M, while the lowest revenue estimate was $3.35M, resulting in an average revenue estimate of $3.49M. In the same quarter a year ago, actual revenue was $3.23MBased on 3 analysts’ estimates, the company’s revenue will be $7.53M in the next fiscal year. The high estimate is $11.27M and the low estimate is $5.48M.
